This study combines behavioural tests with cellular and molecular electrophysiology to clarify molecular mechanisms that control fish feeding. Two partially competitive mechanisms originating from the same neural receptor were found.
In contrast to Tetrapoda, benzodiazepines effect in lower animal taxa is much less studied.
In particular, to the best of our knowledge, there is no data on changes in fish feeding behaviour induced by benzodiazepines, despite this class of compounds having been reported to upregulate overall food consumption when continuously present in water (Belal and Assem, 2011; Brodin et al., 2013) . On top of that, to the best of our knowledge, there is no or little information on the behavioural repercussions of interaction between benzodiazepines and other GABAR ligands in fishes.
A number of marine and fresh-water fish species were introduced as experimental models in food consumption research, due to their relatively simple and easily quantifiable feeding behaviour (Facciolo et al., 2010; Matsuda, 2009; Yamashita et al., 2006) . In particular, Carassius gibelio (Prussian carp) has been established as a popular animal model for research of GABAR-mediated effects on behaviour (Facciolo et al., 2011; Volkoff, 2013) , which provides a rationale for our choice of this species as an experimental object.
A contemporary approach to in vivo receptor modulation and drug design implies combined usage of compounds with different types of molecular action mechanisms: orthosteric (competing for binding site with endogenous ligand) and allosteric (not competing with endogenous ligand). Combinations of different ligand types typically afford unprecedented levels of selectivity and fine tuning of end effects (Christopoulos, 2002; Wenthur et al., 2014) . Thus, due to allosteric action mechanism of benzodiazepines, an important research direction regarding their pharmacological properties is investigation of mutual modulation between benzodiazepine effect and effects caused by GABAR orthosteric ligands.
Taken together, these facts imply the need for behavioural study combined with research of benzodiazepine effects at cellular and molecular level to clarify benzodiazepine-controlled molecular mechanisms of GABARs modulation and correlate them with a profile of behavioural response. Since this approach aggregates data generated at different levels of organisation (cellular, molecular and whole organism), it provides an opportunity for a complex characterisation of perspective chemical compound(s) that have not yet been fully explored.
Phenazepam
[7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one]
(PNZ), is a benzodiazepine which was synthesized in the USSR in 1974 (Bogatskii et al., 1975) and was never in clinical use outside of former Soviet territory. There is scarce data available on PNZ pharmacology, pharmacokinetics, and molecular mechanisms of action, and even less about its impact on behaviour (Maskell et al., 2012) ; however, it was proven to exert a significant modulatory effect on GABA-ergic inhibitory currents (Kopanitsa et al., 2002) and weaken chemical stress reactions in fishes (Potrohov, 2008) . Therefore, we selected PNZ for our study as an under-examined allosteric agonist allowing modulation of GABAR-conducted currents and promising a significant impact on the behavioural profile of Behavioural tests. After acclimation period fish were randomly placed into testing tanks shielded by white paper sheets to minimize external disturbance. Subsequently, the animals were lightly anesthetized in ice water (Facciolo et al., 2011) and injected intraperitoneally with GABAR ligands. Injections were administered caudal to the pelvic fin. To verify that the injections themselves did not influence feeding behaviour, we performed a control test where un-handled fish (n=6) and fish injected with 0.1 ml of 0.9% NaCl (n=6) were compared by feeding behaviour during 8 hours. On the basis of similar behavioural responses (average number of feeding acts) between groups, saline-treated animals were considered as controls for all behavioural experiments. One more control test was performed to determine when fish can be returned into experimental use. In this test we compared feeding behaviour of control fish group and fish groups subjected to injections of 0.3 mg/kg PNZ, 3 mg/kg Bic and 3 mg/kg SR. No difference in feeding acts number was found after three days post injection.
We therefore used each fish for injection of single dose of GABAR ligands in 4-6 days after the end of previous experiment.
Feeding behaviour was monitored and quantified as described previously (Volkoff, 2013 ).
Briefly, a "feeding act" (FA) was defined as an event when the fish consumed food granule (FAC), or engulfed a granule and then "spat" it out (FAS), or pushed a granule with closed mouth (FAP).
For the evaluation of the GABAR effects on the feeding behaviour (number of FAs) fish were injected with GABAR ligands diluted in 0.9% NaCl vehicle and compared to animals that received an i.p. injection of vehicle only (controls). Episodes of convulsive behaviour after injection of GABAR antagonists were defined as those where intermittent rapid swimming in circles and/or sporadic rapid swimming with abrupt changes of direction were observed (Facciolo et al., 2011) . Immobility episodes after injection of benzodiazepine were defined as those where stillness was observed for 10 min (Ide and Hoffmann, 2002) .
Electrophysiology. To prepare brain slices fish were anesthetized with 130 mg/l MS-222 (Posner et al., 2013) , and then rapidly decapitated. The brain was rapidly removed, placed into agar block and transferred to Leica VT1000 vibratome slicing chamber. For slice preparation, we used telencephalon as a part of fish brain which is tightly connected to feeding behaviour (Lin et al., 2000) , and where GABAR response in C. gibelio was clearly demonstrated (Hossein-Javaheri et al., 2017) . 
Results

Behavioural tests
To determine most effective doses for GABAR ligands, we performed a "dose-response" study ( Fig. 1) . In dose-response experiments with 2 hours observation interval starting 15 minutes after drug injection, we aimed to find a GABAR ligand dose that produces the strongest effect without immobility episodes (PNZ) or episodes of convulsive behaviour (GABAR antagonists). Effect of GABAR ligands was tested at overall number of FAs and separately for FAC, FAS and FAP number: see Table 1 for one-way ANOVA results.
PNZ demonstrated a significant gradual increase of number of FAs with incrementing dosage (Fig. 1A) , but without significant effect on any of separate FA components (FAC, FAS, FAP). Dose 0.2 mg/kg was the highest when fish did not demonstrate immobility episodes; on top of that, higher doses did not generate number of FA significantly higher than that for 0.2 mg/kg. Competitive GABA antagonist SR-95531 (SR) and inverse agonist with partial allosteric effect bicuculline (Bic) displayed decrease of FA number with incrementing dosage; the highest effect without convulsion episodes was produced by 2 mg/kg SR and 1.5 mg/kg Bic ( Fig. 1B and C) . In both cases FAC and FAS, taken alone, were found to be significantly influenced by incrementing doses of GABAR ligands (Table 1) .
Flumazenil (FMZ; allosteric antagonist acting at benzodiazepine binding site), being injected in up to 5 mg/kg dose, did not generate a significant effect on overall FA number as well on FAC, FAS and FAP components taken separately (Fig. 1D , To find the optimal time course for combined injections of GABAR ligands, we performed a "time-response" behavioural experiment with optimal ligand doses determined earlier ( Fig.   2A ). We found that PNZ develops a maximum effect 1.5 hour after injection, whereas SR and Bic do so in 1 hour; again, FMZ did not display significant difference from control during all the period of observation.
Next, we tested combined effects of GABAR ligands on C. gibelio feeding behaviour. To do this, we first injected PNZ and, 0.5 hour later (to overlap peak responses), 1.5 mg/kg of Bic, plus different doses of SR (Fig. 2B ). Unexpectedly, a low dose of SR reversed Bic antagonism to PNZ: F(1,90)=4.22, P=0.042, two-way ANOVA for 0.3 mg/kg of SR; whereas a higher dose (0.5 mg/kg) potentiated the Bic effect. To find out whether this paradoxical observation was due to modulation caused by allosteric site after binding of PNZ, we repeated the experiment without PNZ pre-injection (Fig. 2C) Therefore, we proceeded to electrophysiological experiments aiming to test the working hypothesis. To do this, we aimed to dissect effects of PNZ, Bic and SR and their mutual modulation at whole-cell and single-receptor level.
Electrophysiology
As a first part of the electrophysiological section of our study, we performed recordings of spontaneous synaptic GABA-ergic responses in whole-cell mode. We presumed that the decay profile of spontaneous inhibitory post-synaptic currents (s-IPSCs) should consist of two exponents, with one exponent generated by orthosteric (GABA-binding) site effects, and another by effects of the allosteric (benzodiazepine-binding) site. Thus, for quantification of effects generated at orthosteric and allosteric sites, we used the ratio of fitting coefficients (RFC) of two IPSC decay exponents obtained after fitting of averaged s-IPSCs with biexponential function (see Fig. 3D legend for more details of analysis paradigm). Picrotoxin (PTX, 50 µM), applied at the end of each experiment, fully suppressed all synaptic events, thus confirming their exclusive GABA-ergic origin.
Application of PNZ (0.2 M) increased s-IPSC amplitudes and significantly slowed down their decay kinetics ( Fig. 3A and C) (Fig. 3E ).
RFC analysis (Fig. 3D ) demonstrated that PNZ application magnified slow decay exponent, which then remained unaltered by SR, but suppressed by Bic.
This confirmed the different nature of the antagonism to PNZ effect generated by SR and Bic. However, was it due to modulation of the benzodiazepine binding site by one of these antagonists? To clarify the issue, we repeated the experiment on s-IPSCs, but with FMZ applied before Bic (Fig. 4) Finally, we tried to reproduce the pharmacological steps from in vivo experiments with PNZ and FMZ on outside-out patches ( Fig. 2B and D) . We, thus, first applied GABA (1 M) + PNZ (0.2 M) and antagonized their combined effect by Bic (2 M) and Bic (2 M) + SR (2 M) ( Fig. 7A and C 
Discussion
In the present work we performed a combined behavioural and in vitro electrophysiological study of GABAR effects generated by two distinct mechanisms: orthosteric and allosteric.
Correlation of results obtained in these two types of experiments clearly demonstrates control of GABARs over C. gibelio feeding behaviour delivered through both mechanisms in (partially) competitive mode.
Benzodiazepines, which PNZ belongs to, after binding to GABAR initiate two types of potentiation: orthosteric (GABA-dependent) due to enhancement of GABAR affinity to GABA (Lavoie and Twyman, 1996) and allosteric (GABA-independent) through increase of GABAR opening probability (Birnir et al., 2000) . A key point of our research, which all further conclusions depend on, is the nature of SR and Bic action against PNZ ortho-and allosteric effects. Bic and SR were shown to compete for the same binding site with GABA (Johnston, 2013; Wagner and Czajkowski, 2001) . With different experimental approaches, both orthosteric and allosteric action mechanisms were demonstrated for these two compounds (Bai et al., 2001; Heaulme et al., 1986; Krishek et al., 1996; Thompson et al., 1999; Ueno et al., 1997) . The inverse agonist impact of Bic was found to suppress GABA-independent GABAR openings (McCartney et al., 2007; Wlodarczyk et al., 2013) and antagonize effects of GABAR allosteric agonists (Mathers et al., 2007; Ueno et al., 1997) . In our experiments, Bic, but not SR, exerted significant antagonism to allosteric PNZ effect when drugs were applied on outside-out patches with no GABA in perfusion solution ( Fig. 6B and D) . In contrast, they both antagonized the effect of GABA (Fig. 6A and C) , which implies competitive action at orthosteric GABAR binding sites. We thus concluded that, in our research model, SR displays competitive (orthosteric) action only, whereas Bic generates both orthosteric and allosteric effects.
Three different types of feeding behaviour registered in our study undergo different modifications as a result of GABAR activation/deactivation (Fig. 1) . Sum of all three types of feeding events (FA) was found to be most correlated with GABAR ligands action, whereas individual modes of behaviour (FS, FC, FP) may not be influenced significantly by application of particular ligand. This probably reflects the fact that behaviour types under study are closely interrelated, and, as a consequence, easily undergo mutual transition (Helfman, 1986) within general behavioural shift due to GABAR-triggered impact.
An experiment where SR, applied alone, induced a clear decrease in the number of FA competing with endogenous GABA (Fig. 1B) , confirmed the input of orthosteric functional pathway into feeding behaviour. When applied together, SR weakened the antagonistic impact of Bic on the effect of PNZ in both behavioural tests (Fig. 2B ) and single-channel recordings ( Fig. 7A and C) , whereas FMZ, acting at allosteric site, precluded such an effect of SR ( Fig. 2D and 7D ). The most straightforward explanation is that Bic antagonizes both orthosteric and allosteric effects of PNZ, whereas SR, after displacement of Bic, blocks orthosteric effect of PNZ, but leaves its allosteric effect untouched. Hence, these two lines of evidence confirm our working hypothesis about the molecular mechanisms of interaction between SR, Bic, and PNZ. Paradoxical antagonism of SR to Bic effect, displayed in vivo and in vitro, unequivocally points to allosteric GABAR potentiation as one more functional pathway for modulation of fish feeding behaviour.
In experiments on s-IPSCs, PNZ application slowed down overall decay kinetics due to magnification of exponent with higher  value (slow decay component, Fig. 3 ), which is in line with effects of benzodiazepines observed earlier (Poncer et al., 1996) . Bic, being added after PNZ, shifted RFC due to suppression of the slow decay component. In turn, FMZ, which competes with PNZ for allosteric binding site, also suppressed the slow decay component (Fig. 4) , suggesting this component to be generated as a result of allosteric site activation. Since SR was found to deliver its effect exclusively via orthosteric site of action, one may expect SR, when applied after PNZ, to generate a bias of RFC opposite to that generated by Bic: suppression of fast decay component with the slow component left intact.
However, we did not observe any significant RFC shift generated by SR ( Fig. 3 and 5 ). The plausible explanation for this phenomenon is that allosteric activation of spontaneous openings induced by PNZ (see Fig. 6B ) is a stable background input, which does not affect IPSC kinetics. In contrast, increased affinity to GABA after PNZ binding, affects responses generated by GABA efflux only. Thus if both fast and slow (latter -magnified due to increased affinity to GABA) decay components are generated at orthosteric site, SR, displacing GABA, should exert proportional impact on both decay components without changes in RFC, which corresponds to our observations.
Depending on cell type and particular compound, benzodiazepines may affect phasic, tonic, or both types of GABAR-induced inhibition (Bai et al., 2001; Glykys and Mody, 2006; Nusser and Mody, 2002; Yamada et al., 2007) . Tonic GABAR conductance can be produced by two functional types of receptors: GABA-dependent, i.e. activated by low concentrations of ambient GABA (Farrant and Nusser, 2005) , and GABA-independent, i.e. spontaneously opening (McCartney et al., 2007; Wlodarczyk et al., 2013) . Thus, only the ability to modulate tonic conductance through spontaneously opening GABARs may prove the GABAindependent, irreducible to increasing affinity of GABAR to GABA, action of given benzodiazepine. In our experiments, we found that PNZ potentiates phasic and tonic responses of GABARs; tonic conductance was potentiated without the presence of GABA (Fig. 6 ), which resonates with earlier observations on classical benzodiazepine compounds such as diazepam (Birnir et al., 2000) . Hence, our data prove that PNZ delivers its impact through two types of GABAR potentiation: GABA-dependent and GABA-independent.
Another observation, which looks to some extent counterintuitive, is a difference between the behavioural effect of incrementing doses of SR when PNZ was not injected (no significant difference from the effect of Bic only, Fig. 2C ) and when PNZ binding was blocked by FMZ (significant difference from Bic only, Fig 2D) . The possible explanation is that in the native brain benzodiazepine binding site is neither fully activated nor suppressed, and thus generates a certain amount of spontaneous receptor openings (as registered in outside-out patches, Fig. 6 and 7) . SR, being added on top of Bic, enhances Bic antagonistic effect when competes for binding site with endogenous GABA, but removes Bic antagonism to partially activated benzodiazepine site when competes with Bic. These opposite actions prevent development of statistically significant end effect of certain SR doses. However, when benzodiazepine site is blocked by FMZ, competition between SR and Bic does not generate any indirect effect connected to riddance of Bic allosteric action, thus allowing unhindered development of antagonism due to GABA displacement by SR. If this is the case, this also implies regulation of feeding behaviour by two types of GABAR signalling:
phasic (synaptic IPSCs generated by GABA efflux) and tonic (spontaneous GABAR openings all over the cell surface).
Our study thus has several outcomes. As a fundamental result, we proved existence of two distinct molecular mechanisms regulating feeding behaviour through GABARs, which act in partially competitive manner. Due to relatively conservative nature of GABAR structure in vertebrates (Martyniuk et al., 2007) , these two mechanisms with given interaction should be expected in higher taxons as well as in fishes. If true, this makes C. gibelio a convenient and universal experimental model for further studies of GABAR effects on feeding behaviour. On top of that, we filled a data gap in behavioural effects of PNZ which is perspective, albeit under-researched compound for treatment of GABAR-connected disorders.
After impetuous growth during last decades, aquaculture now supplies more than a half of the total fish for human consumption; in parallel, aquaculture's share of the world's fishmeal 
